These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 10377514)

  • 1. New collaborations make pharmacogenomics a SNP.
    Dawson E
    Mol Med Today; 1999 Jul; 5(7):280. PubMed ID: 10377514
    [No Abstract]   [Full Text] [Related]  

  • 2. Pharmacogenetics, pharmacogenomics, and cardiovascular therapeutics: the way forward.
    Terra SG; Johnson JA
    Am J Cardiovasc Drugs; 2002; 2(5):287-96. PubMed ID: 14727958
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Pharmacogenomics of cardiovascular pharmacology].
    Tanaka T; Oka T; Iwao H
    Nihon Yakurigaku Zasshi; 2006 Sep; 128(3):130-2. PubMed ID: 16971774
    [No Abstract]   [Full Text] [Related]  

  • 4. Cardiovascular Pharmacokinetics, Pharmacodynamics, and Pharmacogenomics for the Clinical Practitioner.
    Sleder AT; Kalus J; Lanfear DE
    J Cardiovasc Pharmacol Ther; 2016 Jan; 21(1):20-6. PubMed ID: 26054891
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacogenetics in cardiovascular diseases: State of the art and implementation-recommendations of the French National Network of Pharmacogenetics (RNPGx).
    Lamoureux F; Duflot T;
    Therapie; 2017 Apr; 72(2):257-267. PubMed ID: 28237404
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacogenomics in cardiovascular diseases.
    Mukherjee D; Topol EJ
    Prog Cardiovasc Dis; 2002; 44(6):479-98. PubMed ID: 12077721
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiovascular pharmacogenomics.
    Roden DM
    Circulation; 2003 Dec; 108(25):3071-4. PubMed ID: 14691022
    [No Abstract]   [Full Text] [Related]  

  • 8. Pharmacogenomics - it's not just pharmacogenetics.
    Bailey DS; Bondar A; Furness LM
    Curr Opin Biotechnol; 1998 Dec; 9(6):595-601. PubMed ID: 9889141
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacogenomics and management of cardiovascular disease.
    Howe LA
    Nurse Pract; 2009 Aug; 34(8):28-35; quiz 36. PubMed ID: 19638892
    [No Abstract]   [Full Text] [Related]  

  • 10. Pharmacogenetics and pharmacogenomics: adverse drug reactions.
    Jorgensen A; Alfirevic A
    Pharmacogenomics; 2008 Oct; 9(10):1397-401. PubMed ID: 18855528
    [No Abstract]   [Full Text] [Related]  

  • 11. [Cardiovascular pharmacogenomics].
    Ahlehoff O; Hansen PR
    Ugeskr Laeger; 2009 Apr; 171(17):1405-7. PubMed ID: 19413939
    [TBL] [Abstract][Full Text] [Related]  

  • 12. From SNPs to functional studies in cardiovascular pharmacogenomics.
    Cresci S
    Methods Mol Biol; 2008; 448():379-93. PubMed ID: 18370238
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiovascular drugs and the genetic response.
    Dandona S
    Methodist Debakey Cardiovasc J; 2014; 10(1):13-7. PubMed ID: 24932357
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacogenomics of lipid-lowering therapies.
    Hu M; Tomlinson B
    Pharmacogenomics; 2013 Jun; 14(8):981-95. PubMed ID: 23746191
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacogenomics in cardiovascular disease: the role of single nucleotide polymorphisms in improving drug therapy.
    Mango R; Vecchione L; Raso B; Borgiani P; Brunetti E; Mehta JL; Lauro R; Romeo F; Novelli G
    Expert Opin Pharmacother; 2005 Dec; 6(15):2565-76. PubMed ID: 16316297
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacogenomics in cardiology--genetics and drug response: 10 years of progress.
    Cavallari LH; Weitzel K
    Future Cardiol; 2015 May; 11(3):281-6. PubMed ID: 26021633
    [No Abstract]   [Full Text] [Related]  

  • 17. Pharmacogenomics in cardiovascular diseases.
    Mukherjee D; Topol EJ
    Curr Probl Cardiol; 2003 May; 28(5):317-47. PubMed ID: 14614445
    [No Abstract]   [Full Text] [Related]  

  • 18. Clinical association between pharmacogenomics and adverse drug reactions.
    Zhou ZW; Chen XW; Sneed KB; Yang YX; Zhang X; He ZX; Chow K; Yang T; Duan W; Zhou SF
    Drugs; 2015 Apr; 75(6):589-631. PubMed ID: 25895462
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Future directions in pharmacogenomics discovery in cardiovascular disease.
    Friede KA; Voora D
    Pharmacogenomics; 2018 Apr; 19(5):375-377. PubMed ID: 29569527
    [No Abstract]   [Full Text] [Related]  

  • 20. Pharmacogenomic Challenges in Cardiovascular Diseases: Examples of Drugs and Considerations for Future Integration in Clinical Practice.
    Chatelin J; Stathopoulou MG; Arguinano AA; Xie T; Visvikis-Siest S
    Curr Pharm Biotechnol; 2017; 18(3):231-241. PubMed ID: 28117005
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.